HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Anabuki Selected Research

Jun Anabuki Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
12/2012 - 10/2012
1Cognitive Dysfunction
01/2020
1Catalepsy
01/2020
1Schizophrenia (Dementia Praecox)
01/2020
1Hyperglycemia
12/2012
1Dyslipidemias (Dyslipidemia)
12/2012
1Hypoglycemia (Reactive Hypoglycemia)
10/2012

Drug/Important Bio-Agent (IBA)

23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
12/2012 - 10/2012
2Dipeptidyl-Peptidase IV InhibitorsIBA
12/2012 - 10/2012
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020
1ProlactinIBA
01/2020
1Antipsychotic Agents (Antipsychotics)IBA
01/2020
1MT-3014IBA
01/2020
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
10/2012
1ThiazolidinesIBA
10/2012

Therapy/Procedure

1Glycemic Control
12/2012